Vrije universiteit Brussel
Brussels, Belgium
NCT Number: NCT04974229
A longitudinal observational cohort study to investigate the value of prognostic factors, here sensory profiles , and others, in the development of central sensitization in the low back pain population. A type 2 prognostic factor research following the PROGRESS framework. Sensory profiles are identified a prognostic factors which can predict the development of central sensitization in the low back pain population.
Looking for future studies?
Notify Me18 year–64 year
All sexes
Observational
Brussels, Belgium
After performing an univariable linear regression analyses the regression model predicts the dependent variable, central sensitization, significantly, and the models are significant prediction factors of the development of central sensitization. In unadjusted analyses, all four sensory profiles were significantly associated with the development of central sensitization (P<0.001).
After adjusting for pain, disability, age, and duration of low back pain, baseline sensory profiles remained significant predictors of central sensitization. On the other hand, all other predictor variables did not contribute to the prediction of central sensitization.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
In line with the Dutch guideline for non-specific low back pain, Standard usual care or non-specific low back pain was applied.
Other names: In line with the Dutch guideline for low back pain, Standard usual care or non-specific low back pain was applied.
Time frame: 12 weeks
The validated questionnaire Central Sensitization Inventory which scores on a 5 point scale ranging from 0-100. A higher score indicated a higher degree of central sensitization.
Time frame: 0 weeks
Adolescent/Adult Sensory Profile measures 4 sensory profiles (sensation avoiding, sensation sensitive, sensation seeking, low registration) on ad 5 point scale, and is validated in the low back pain population. Scores range from 15-60 points per variable. A higher score means a higher degree of sensitivity for the specific sensory profile.
Time frame: Baseline (0 weeks)
Numeric Pain Rating Scale measures experienced level of pain, which consist of one question ranging van 0 (no pain)-10 (most extreme pain imaginable).
Time frame: Baseline (0 weeks)
The Pain Disability Index evaluates the effect on seven life-related domains. Each domain is measured by 1 question, with a total of 7 questions, on an 11 point scale, from 0 (no disability) to 10 (completely disabled). Previously established reliability and internal consistency are acceptable in patients with chronic pain.
Time frame: Baseline (0 weeks)
The included age (years) ranged from 18-60 score. A higher age indicates a worse prognoses of low back pain.
Time frame: Baseline (0 weeks)
Duration of low back pain was assessed in weeks. The included duration of low back pain ranged from 0-6 weeks. A longer duration is not better or worse.
Vrije Universiteit Brussel
Other
Sensory Profiles as Predictors of Central Sensitization in Low Back Pain: A Prospective Cohort Study.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07063966
Environmental Conditions, Motor Development
Zonguldak, Ereğli, Turkey (Türkiye)
View Trial DetailsNCT06967870
Colic, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Bursa, Osmangazi, Turkey (Türkiye)
View Trial DetailsNCT06967363
Acute Low Back Pain, Acute Pain
Beijing, Beijing Municipality, China
View Trial DetailsNCT04730791
Central Sensitisation, Chronic Pain
Lamia, Central Greece, Greece
View Trial Details